Stock Research

Investors are expecting clarity on Arena’s Lorcaserin
Posted on May 01, 2012 at 02:44 AM EDT
Shares of Arena Pharmaceuticals (ARNA)-- a development-stage company that is in the process of developing a prescription weight-loss drug called Lorcaserin, have been on a wild ride.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here